(Q34631331)

3 August 2017

1 reference

title

'Real world' pragmatic clinical trials: what are they and what do they tell us? (English)

1 reference

3 August 2017

Peter J Helms

1

1 reference

3 August 2017

publication date

1 February 2002

1 reference

Pediatric Allergy & Immunology

3 August 2017

published in

1 reference

3 August 2017

volume

13

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

4-9

1 reference

Efficacy and safety of inhaled steroid and cromone treatment in school-age children: a randomized pragmatic pilot study.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

Third International Pediatric Consensus statement on the management of childhood asthma. International Pediatric Asthma Consensus Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

Societal and health care benefits of early use of inhaled steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

Airway mucosal inflammation even in patients with newly diagnosed asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

Measuring compliance with inhaled medication in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

Compliance with inhaled asthma medication in preschool children

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

Pragmatic versus explanatory trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

What are pragmatic trials?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

Pragmatic randomised controlled trial of local corticosteroid injection and naproxen for treatment of lateral epicondylitis of elbow in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

Open access follow up for inflammatory bowel disease: pragmatic randomised trial and cost effectiveness study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

Long-term effects of budesonide or nedocromil in children with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

21 January 2018

Licensing of medicines

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

Unlicensed and off label drug use in paediatric wards: prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

Off label and unlicensed drug use among French office based paediatricians

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

Unlicensed and off label drug use in neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

Unlicensed and off label prescribing of drugs in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

Relative safety and efficacy of inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

Asthma treatment with a new corticosteroid aerosol, budesonide, administered twice daily by spacer inhaler

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

Disodium Cromoglycate (FPL 670) (‘Intal’*): a Specific Inhibitor of Reaginic Antibody–Antigen Mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

Inhaled disodium cromoglycate as maintenance therapy for childhood asthma: time to consign to history?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

Long-acting beta(2)-agonists in management of childhood asthma: A critical review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

Review of prescribed treatment for children with asthma in 1990.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

7 January 2021

Asthma medication in children-1991

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

7 January 2021

Decrease in hospitalization for treatment of childhood asthma with increased use of antiinflammatory treatment, despite an increase in prevalence of asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

7 January 2021

Inflammation and airway function in asthma: what you see is not necessarily what you get

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

7 January 2021

Comparison of patients' compliance with prescribed oral and inhaled asthma medications

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

7 January 2021

The pragmatic approach to stroke trial design: stroke register, pilot trial, assessment of neurological then functional outcome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

7 January 2021

Is bleeding time measurement useful for choosing the liver biopsy route? The results of a pragmatic, prospective multicentric study in 219 patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

7 January 2021

Octreotide compared with placebo in a treatment strategy for early rebleeding in cirrhosis. A double blind, randomized pragmatic trial

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

7 January 2021

Pediatric asthma: "Real world" measures of effectiveness.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

7 January 2021

Early introduction of inhaled steroids in wheezing children presenting in primary care. A pilot study. EASE Study Group.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

7 January 2021

Status of drug approval processes and regulation of medications for children

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

7 January 2021

Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

7 January 2021

A comparison of inhaled budesonide and beclomethasone dipropionate in childhood asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

7 January 2021

Inhaled disodium cromoglycate (DSCG) as maintenance therapy in children with asthma: a systematic review

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

7 January 2021

Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00194.X

7 January 2021

10.1034/J.1399-3038.2002.00194.X

Identifiers

DOI

1 reference

3 August 2017

1 reference